Tag: Biotech
GSK launches Shingrix in India- A vaccine for the prevention of...
New data show Shingrix can provide at least 10 years of protection against shingles in adults aged 50 years and over
Biotech industry in India holds a plethora of opportunities
India has witnessed some landmark projects which has shaped the uptake of Genomics in the country, writes Praveen Gupta, Managing Director, Premas Life Sciences
Biotech is the key to unlock a sustainable future
From addressing climate change, transforming food systems, and enabling healthier lives, the biotechnology has many more possibilities, writes Krishna Mohan Puvvada, Regional President, India, Novozymes
BioVoice eMagazine April 2023 | Issue 4 | Volume 4
Click to Read: April 2023 Edition of BioVoice eMagazine
The Cover Story Healthcare 3.0 Evolving Landscape of Digital Health examines the digital healthcare story in...
ABLE’s 20th Anniversary: India emerging as world’s major bioeconomy, says Dr...
The Union Minister said that in the Global Innovation Index 2022, India has moved to 40th rank from 81st position
ABLE’s 20th Anniversary: Realistic policies & regulations critical for bioeconomy to...
Kiran was speaking at the 20th Anniversary Celebration of the Association of Biotechnology Led Enterprises (ABLE) on April 07, 2023. The theme of the event was "India-A Resilient Global Biotech Destination."
India’s Evergreen Vaccine Story
India's biotechnology industry is positioned to become a significant engine of the Indian economy, writes Suchitra Ella, Managing Director, Bharat Biotech International Limited
Building a Sustainable BioPharma Industry
At the cusp of a transformation, biopharma industry needs to adopt a sustainability mindset in every aspect of drug development, writes Gaurav Kaushik
BioVoice eMagazine March 2023 Issue 3 Volume 4
Click to Read: March 2023 Edition of BioVoice eMagazine
The Cover Story, "The Torchbearers of Indian bioscience- Profiling India’s Top 20 Promising Bioscience Innovators" in the...
Parexel launches ‘New Medicines, Novel Insights’ expert series
New evidence-based reports offer timely analysis and actionable guidance to drug developers bringing critical new therapies to market